Short-Term Debt to Capital: LeMaitre Vascular Inc (LMAT)

LeMaitre Vascular, Inc. (LMAT) produces specialized consumables for vascular surgeries, leveraging a monopoly position in its niche and inelastic demand to ensure exceptional profitability. The historical price action on this chart reflects a debt-to-equity ratio of 0.00, linking financial stability to the risks of regulatory audits or patent disputes. A steady cash flow is sustained by the company's dominance in a narrow medtech segment.

The stability of LeMaitre Vascular, Inc. (LMAT) is based on high surgeon confidence in its certified implants, which minimizes operational risks. This resilience is confirmed via the ratio of short-term liabilities to equity, which measures the balance sheet's dependence on imminent payments. By analyzing the history of short-term loans relative to equity, an investor assesses the company's margin of safety: low values confirm financial autonomy, while sharp spikes signal a shift in credit strategy.